ACTA2 and pancreatic neoplasm: Conditional Prrx1 loss of function in Sm22 (Tagln) positive CAFs in a mouse model of pancreatic cancer also promoted in vitro an activated phenotype with an increase in ACTA2 and COL1 expression levels (Feldmann et al., 2021).